Medlr AstraZeneca Pharma India Secures CDSCO Approval for Durvalumab in LS-SCLC Treatment AstraZeneca Pharma India gains CDSCO approval for durvalumab in LS-SCLC, marking a breakthrough in early-stage lung cancer treatment post-CRT.
News AstraZeneca Pharma India to Sell Bengaluru Plant AstraZeneca Pharma India's decision to divest its Bengaluru facility marks a strategic shift in its global manufacturing network.
